Managing Patients With Heart Failure All the Way to a Heart Transplant

Rebecca Pirozzi1

  • 1Allegheny General Hospital, Pittsburgh, Pennsylvania.

Insights

Heart transplantation offers a vital treatment for end-stage heart failure. Comprehensive evaluations and advanced therapies like the left ventricular assist device (LVAD) are crucial for successful outcomes.

Area of Science:

  • Cardiology
  • Transplantation Medicine
  • Medical Devices

Background:

  • End-stage heart failure necessitates advanced treatment options.
  • Heart transplantation is a life-saving procedure for eligible patients.
  • Advanced therapies are often required to support patients awaiting transplant.

Purpose of the Study:

  • To outline the comprehensive evaluation process for heart transplant candidates.
  • To highlight the role of advanced therapies, such as the left ventricular assist device (LVAD), in bridging patients to transplant.
  • To emphasize the importance of a multidisciplinary approach in managing heart failure patients undergoing transplantation.

Main Methods:

  • Extensive pre-transplant patient evaluation.
  • Risk assessment for advanced cardiac support therapies.
  • Multidisciplinary team collaboration for patient management.

Main Results:

  • Patients with end-stage heart failure can be effectively managed with advanced therapies.
  • Left ventricular assist device (LVAD) implantation is a common requirement for safe transit to heart transplantation.
  • A coordinated, multidisciplinary strategy ensures patient safety and post-transplant success.

Conclusions:

  • Heart transplantation is a feasible option for selected end-stage heart failure patients.
  • Thorough pre-transplant assessment and the use of advanced therapies like LVAD are critical.
  • A multidisciplinary approach is essential for optimizing patient outcomes before and after heart transplantation.

Related Concept Videos

Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
330
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
952
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
3.8K
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
903
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
348
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
983